Menu

Jumping Genes Inactivated with CRISPR in Pigs

The study could pave the way for transplanting porcine organs to humans without the risk of reigniting endogenous retroviruses.

Aug 10, 2017
Shawna Williams

Piglets whose genes were altered using CRISPREGENESISThe gene-editing technique CRISPR-Cas9 has received ample attention for its potential to improve human health via gene therapy. Today (August 10), an international team of researchers announced a step toward giving it an entirely different role in medicine: enabling xenotransplantation—in this case, of pig organs into humans. As reported in Science, the group used CRISPR to disable viral DNA lodged in the pig genome and then grew healthy piglets from the edited cells.

Pig organs are about the same size as humans,’ so some scientists and transplant surgeons see them as candidates to solve the problem of a shortage of organ donors, reports The New York Times. Previous experiments have worked toward customizing pig organs to make them compatible with human recipients. But one concern has been the potential for the zombies of pig infections past, known as porcine endogenous retroviruses (PERVs), to reanimate and infect human organ recipients.

See “Scientists Create First Human-Pig Chimeric Embryos”

The research group identified 25 PERVs in pig genomes, then used CRISPR-Cas9 to inactivate all of them. They inserted the edited genetic material into pig eggs to create embryos, which were implanted in sows and developed into piglets, reports New Scientist.

“This research represents an important advance in addressing safety concerns about cross-species viral transmission,” study author Luhan Yang of the biotech company eGenesis tells The Guardian. “Our team will further engineer the Perv-free pig strain to deliver safe and effective xenotransplantation.”

The New York Times notes that patients with diabetes have been treated with pig pancreatic cells, and burn victims with pig skin grafts, with no apparent problems so far caused by PERVs.

Jay Fishman, co-director of the transplant program at Massachusetts General Hospital, questions whether PERVs were really so dangerous in the first place. “We don’t know that if we transplant pig organs with the viruses that they will transmit infections, and we don’t know that the infections are dangerous,” he tells the Times. “I think the risk to society is very low.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.